2 suspended. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Suspended 2 |
| Phase 3 | 1 | Suspended 1 |
Follow Covid19: new trials by email Literature Review of Covid19 trials Research Report on Covid19
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety, Tolerability and Efficacy Of S-1226 in Moderate Severity Covid-19 Bronchiolitis/Pneumonia S-1226 - Covid19, SARS-CoV-2 Infection | Phase 2 | Suspended | SolAeroMed Inc. | 30 | 2021-09-15 | 2021-08-23 |
| Study of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients: Sarilumab, Azithromycin, Hydroxychloroquine Trial - CORIMUNO-19 - VIRO Sarilumab, Azithromycin, Hydroxychloroquine - COVID19, SARS-CoV-2 Infection | Phase 2 / Phase 3 | Suspended | Assistance Publique - Hôpitaux de Paris | 27 | 2020-04-11 | 2020-05-06 |
COVID-19 (2)
Coronaviridae Infections (2) · Coronavirus Infections (2) · Infections (2) · Lung Diseases (2) · Nidovirales Infections (2) · Pneumonia (2) · Pneumonia, Viral (2) · RNA Virus Infections (2) · Respiratory Tract Diseases (2) · Respiratory Tract Infections (2) · Virus Diseases (2)
Azithromycin (1) · Hydroxychloroquine (1) · perfluorooctylbromide and CO2 drug combination (1) · sarilumab (1)
Assistance Publique - Hôpitaux de Paris (1) · SolAeroMed Inc. (1)
Canada (1) · France (1)